Literature DB >> 28921225

N-methyl-D-aspartate receptor agonists and antagonists partially affect the duration of ketamine anesthesia in the rat.

Tatsuhiko Kurato1, Yuji Kiuchi2, Hajime Yasuhara3, Katsuji Oguchi4, Hiroshi Goto5, Kasumi Arakawa5.   

Abstract

The effects of intracerebroventricular injection of excitatory amino acids which act on the N-Methyl-D-aspartate (NMDA) receptor complex on the duration of loss of righting reflex (DLRR) induced by intravenous injection to ketamine (20 mg/kg) were investigated in rats. Ketamine-induced DLRR was 10.3 min, but NMDA receptor agonistsD-alanine (200 μg) or NMDA (0.15 μg) did not change DLRR. However,D-alanine combined with NMDA significantly shortened DLRR (7.7 min). The NMDA receptor antagonist 7-chlorokynurenic acid (10 μg) alone prolonged DLRR significantly (16.2 min), but not when combined withD-alanine. These data suggest that NMDA receptor blockade contributes at least partially to the mechanism of ketamine anesthesia.

Entities:  

Keywords:  7-Chlorokynurenic acid; D-Alanine; Ketamine anesthesia; N-Methyl-D-aspartate; NMDA receptor

Year:  1995        PMID: 28921225     DOI: 10.1007/BF02479872

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  13 in total

1.  The noncompetitive N-methyl-D-aspartate antagonists, MK-801, phencyclidine and ketamine, increase the potency of general anesthetics.

Authors:  L C Daniell
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

2.  Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine.

Authors:  J F MacDonald; Z Miljkovic; P Pennefather
Journal:  J Neurophysiol       Date:  1987-08       Impact factor: 2.714

3.  Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices.

Authors:  A M Thomson; V E Walker; D M Flynn
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

4.  The noncompetitive N-methyl-D-aspartate receptor antagonist, MK-801 profoundly reduces volatile anesthetic requirements in rabbits.

Authors:  M S Scheller; M H Zornow; J E Fleischer; G T Shearman; T F Greber
Journal:  Neuropharmacology       Date:  1989-07       Impact factor: 5.250

5.  Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro.

Authors:  D Martin; D Lodge
Journal:  Neuropharmacology       Date:  1985-10       Impact factor: 5.250

Review 6.  Neurochemical aspects of the N-methyl-D-aspartate receptor complex.

Authors:  Y Yoneda; K Ogita
Journal:  Neurosci Res       Date:  1991-02       Impact factor: 3.304

7.  The glycine site modulates NMDA-mediated changes of intracellular free calcium in cultures of hippocampal neurons.

Authors:  M W Oliver; J A Shacklock; M Kessler; G Lynch; K G Baimbridge
Journal:  Neurosci Lett       Date:  1990-07-03       Impact factor: 3.046

8.  Glycine potentiates the NMDA response in cultured mouse brain neurons.

Authors:  J W Johnson; P Ascher
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

9.  Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor?

Authors:  T Yamamura; K Harada; A Okamura; O Kemmotsu
Journal:  Anesthesiology       Date:  1990-04       Impact factor: 7.892

10.  Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones.

Authors:  J F MacDonald; M C Bartlett; I Mody; P Pahapill; J N Reynolds; M W Salter; J H Schneiderman; P S Pennefather
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.